3 FDA-approved drugs tested in new longevity trial: Inside the clinical debate (MDLinx)

MDLinx quoted Sean Curran regarding a non-USC study investigating how the drugs rapamycin, dapagliflozin, and semaglutide affect aging. “In non-human studies, medications have been used to extend longevity across organisms, from simple yeast cells to more complex mammals,” Curran said. “Although this is the question everyone wants the answer to, perhaps the more important question we should be asking is, ‘To what extent can a medication influence health across the lifespan, including in older adults?’ Maximizing the health, especially at older ages, is far more important than extending longevity.”